December 8, 2022
Tag: Breast Cancer Clinical Program
December 8, 2022
ASCO Post: Yara Abdou, MD, on Race and Clinical Outcomes in the RxPONDER Breast Cancer Trial
December 7, 2022
Targeted Oncology: RxPONDER Reveals Worse Outcomes Shown in Black Women With HR+ Breast Cancer
December 7, 2022
Cancer Therapy Advisor: Investigating Racial Disparities in HR+, HER2- Breast Cancer
December 7, 2022
OncLive: Dr. Abdou on Race and Clinical Outcomes in Breast Cancer
December 7, 2022
Pharmacy Times: Black Women With Breast Cancer Show Worse Outcomes Than Peers
December 6, 2022
Onco’Zine: Study Shows Black Women With Breast Cancer May Have Worse Outcomes
November 22, 2022
Targeted Oncology: Reviewing the Latest Advancements in Treatment of TNBC
September 13, 2022
Specific sequence of drugs reduces cost of treating metastatic breast cancer while preserving quality of life
Researchers developed three different computer models to predict how a hypothetical set of patients with specific types of metastatic breast cancer would respond to different sequences and types of chemotherapy.
June 17, 2022
Study finds that accurate diagnostic mammography outcomes vary by racial and ethnic groups
A study by Sarah J. Nyante, PhD, MSPH, and colleagues found that the rate of diagnostic accuracy is highest in non‐Hispanic white women and lowest in Hispanic women.